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ةصلاخلا 
:ثحبلا هيفلخ  .ثايفشخسمٌا  هيب ام َِذعٌا ساشخوا يف تببسخمٌاَ تيصاٍخولاا تيضشمٌا ميراشضٌا عاُوأ شزوأ هم ًيساضوضٌا فئاَضٌا
تيُيحٌا ثاداضمٌا هم ٌُ ذياسُىيلاوُىيملأا  داضمٌا ازٌ ًمع ًيىيواىيم ظيبزح ًيٍمع نإ . ميراشضٌا هم عُىٌا ازٌ ذض تمذخخسمٌا تمٍمٌا تيئايميىٌا
 ميضوأ صاشفأ َأ داضمٌا ازٍب تللاعٌا ثار ثاميضولأا شييغح كيشط هع امأ  نُىي16SrRNA methylase  . 
:فذهلا ىيملأا ثاداضم تمَامم ساشخوا ذيذحح ٌُ تساسذٌا يزٌ هم فذٌٍا نأ ثاىيعٌا هم تٌَضعمٌا ًيساضوضٌا فئاَضٌا ثلاضع يف صذياسُىيلاوُ
ًيشصاىٌا ًىيذم ثايفشخسم يف هيذفاٌُاَ هيذلاشٌا ّضشمٌٍ تيشيشسٌا.   
 :ةيجهنملا عمص ّمح355 ثاعُمضم دلار ٌّإ اٍعمص سداصم بسحب ثاىيعٌا جمُسلَ تيشصاىٌا يف ًسيئس ثايفشخسم دلار هم تيشيشس تىيع 
 (160  َ نرأ تحسم 105َ قَشح تحسم90   ًيذئاع تيُيحُميىٌاَ تيعسضٌا ثاصُحفٌا شئاخو ثشٍظأ ذيح ،)ساسدإ تىيع65  ايشيخىبٌ ًٌضع
ًيساضوضٌا تفئاضٌاPseudomonas aeruginosa تطساُب اٍصيخشح ذيوأح محَ ، API-. 20E  ياضح ثلاضعٌا تيساسح ثشبخخأ.18  هم ًاعُو
يبشيو ـٌ صشمٌا ساشخوإ تميشطب تيُيحٌا ثاداضمٌا- هم ًو ثاىيص ذصاُح هع فشىٌا مح .سَاب AACs, APHs, ANTs 
,16rRNAmethylase,  ةشمٍبٌا ميضوا ًعافح تٍسٍس تيىمح يامعخساب ذياسُىيلاوُىيملأا هم ًللأا ٍّع ذحاَ عُىٌ تمَاممٌا ثلاضعٌٍPCR. 
:جئاتنلا ع شئاخىٌا ثشٍظأ  ًيذئا65  عُمضم هم ًيساضوضٌا تفئاضٌا ايشيخىبٌ ًٌضع355  نأ ايشيخىبٌا هٍخٌ تيساسحٌا سابخخا شئاخو جىيب امو ، ًٌضع
 ناىٌ92 ( تٌضع44.6% ثاداضمب تٍزمخمٌاَ ًساسذٌا يزٌ يف  تٍمعخسمٌا ًيذيسُىيلاوُىيملأا ثاداضم هم ذحاَ عُىٌ ًللأا ٍّع ًمَامم)
هيسياماخىضٌا َ هيساىيملأا  هسياماخىضٌٍ ًبسو ٍّعأ جواو ذيح هيسيامٍخىٌا َ هيسياماشبُخٌا َ(44.6%)  هيساىيملأٌ ًبسو ًلأ َ(18.5%)0  امو
 ًيخسلاا تعُمضمٌ تٍلاىٌا ثاميضولأٌ ةشفشمٌا ثاىيضٌا هم تعبسأ ناىٌ نأ شئاخىٌا ثشٍظأACC  يف يدُصُم(21)  ًمَاممٌا ثلاضعٌا هم ًٌضع
ناو ذيح صذياسُىيلاوُىيملأٌ  هيضٌاaac(6')-Ib  تبسىب اذصاُح شزولأا ٌُ (69%)  ًيٍيaac(6')-I  ًبسىب(24.1%)  هيىيضٌا هم ًو امأ 
aac(3)-II  َ aac(3)-I  يٌاُخٌا ٍّع تبسىب اشٍظ ذمف  (10.3%) اشٍظ ذل اواو هيىيضٌ ضيمم اساشىح دُصَ ٌّا ًساسذٌا جحضَأَ. يٌاُخٌا ٍّع
 تبسو جواو ذيح ةذحاٌُاتٌضعٌا يفaac(6')-Ib+aac(6')-I َ+ aac(6')-Ib  aac(3)-II (12.7%) َ(6.9%)  ثاىيص امأ. يٌاُخٌا ٍّع
16SrRNA methylase(armA, rmtA, rmtD and npmA)َaph (3')-VI and ant (4')-IIb genes  عيمص يف اٍىع فشىٌا مخي مٍف
. ثاىيعٌا 
: جاتنتسلاا ٌا فئاَضٌا ثلاضع تمَامم يف ًظُحٍم ةدايص ناىٌ دسُمٌا ناو ذلَ صذياسُىيلاوُىيملأا ثاداضمٌ ًيساضوضaac(6')-Ib   بٌاغٌا ٌُ
.ثارسُمٌا تيمب هع 
: تايصىتلا  تمَاممٌا عاسحا عىمٌ صذياسُىيلاوُىيملاا تعُمضم تصاخَ تيحايحٌا ثاداضمٌا هم سلاعٌا عُو هيعحَ ذيذحخٌ ًٍماش ًمع تطخ عضَ
.ًيساضوضٌا فئاَضٌا ايشيخىب ًبل هم اٌٍ 
Abstract  
Background: Pseudomonas aeruginosa is one of the primary opportunistic pathogens responsible for 
nosocomial infections. Aminoglycosides are an important component of antipseudomonal 
chemotherapy. The inactivation of drugs by modifying enzymes and 16S rRNA methylase are the 
most common mechanisms of aminoglycoside resistance. 
Aim of the study: Investigate the occurrence of aminoglycoside resistance and the incidence of the 
16S rRNA methylase and resistance-modifying enzyme genes in P. aeruginosa isolated from several 
hospitals in Al-Nasseryia province.  
Methods: Atotal of 355 clinical isolates were collected from three main hospitals in Al-Nasseryia 
city. The isolates were classified according the source of collection to three groups (160 ear swab, 
105 burn swab and 90 urine samples). The results of culture and biochemical tests showed that 65 
isolate was Pseudomonas aeruginosa, which then confirmed by API-20E. Antibiotic susceptibility 
test (by using the Kirby-pour technique) was performed to all these isolates by using 18 type of 
antibiotics. The isolates that resistance to at least one type of aminoglycosides were screened for the 
presence of modifying enzyme genes (AACs, APHs, ANTs)and16S rRNA methylase genes by 
polymerase chain reaction. 
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Results:65 (18.3%) isolates of P. aeruginosa were identified.The results of antibiotic susceptibility 
test showed that 29 isolate (44.6%) resistance to at least one type of aminoglycosides which 
represented by gentamicin the highest (44.6%) and amikacin (18.5%) the lowest. Four genes of AAC 
were found in 21 (72.4%) aminoglycosides resistant isolates, aac(6')-Ib (69%), aac(6')-I (24.1%), 
aac(3)-II and aac(3)-I (10.3% each). The most repeated combinations, aac(6')-Ib+aac(6')-I and 
aac(6')-Ib+aac(3)-II, were detected in 12.7% and 6.9% of isolates, respectively. Negative results for 
the presence 16rRNA methylase (armA, rmtA, rmtD, and npmA), aph (3')-VI and ant (4')-IIb genes. 
Conclusions: The aminoglycosides resistance rates in P. aeruginosa were roughly high in Al-
Nasseryia, and most of the resistance isolates harbored aac (6')-Ib gene.  
Recommendations:In order to overcome the worrisome development of increased resistance to 
antibiotics in general and aminoglycoside in particular, continued national surveillance programs are 
crucial. 
Keywords:Pseudomonas aeruginosa; Antibiotic; Resistance; Aminoglycosides Modifying Enzymes 
(AMEs). 
INTRODUCTION 
Pseudomonas aeruginosa is one of the most common Gram-negative pathogens 
associated with nosocomial infections 
(1)
. P. aeruginosa can acquire resistance to various 
antimicrobial agents, such as aminoglycosides, β-lactams and fluoroquinolones. 
Aminoglycosides are an important component of antipseudomonal chemotherapy 
(2, 3)
. 
Resistance to aminoglycosides occurs via enzymatic modification, impermeability, 
the activity of efflux pumps (MexXY-OprM)
(4)
, the PhoP-PhoQ system
(5)
, ndvB dependent 
biofilm formation and the activity of 16S rRNA methylase 
(6)
. Among these mechanisms, the 
inactivation of drugs by plasmid-encoded modifying enzymes is the most common. These 
modifying enzymes include aminoglycoside phosphoryl transferase (aph), aminoglycoside 
acetyltransferase (aac), and aminoglycoside nucleotidyl transferase (ant) 
(7, 8)
. More recently, 
16S rRNA methylase genes were identified in P. aeruginosa
(9)
. There are few documented 
data available in Iraq on the resistance of P. aeruginosa isolates 
(10, 11)
. Moreover, there is no 
study addressing the pattern of antibiotic resistance of P. aeruginosa in Al-Nasseryia 
province. Thus, the aim of the present study was to investigate the occurrence of 
antipseudomonal as well as aminoglycoside resistance and the incidence of the 16S rRNA 
methylase and resistance-modifying enzyme genes in P. aeruginosa isolated from several 
hospitals in Al-Nasseryia province.  
METHODOLOGY: 
During the period from November 2012 to April 2013, a total of 355 non-duplicate 
clinical samples were collected from patients visited/or admitted to three main hospitals in 
the Al-Nasseryia city. The study population was 54.9% male and 45.1% female. The 
specimens were isolated from ear swab (45.1), wound (29.6%) and urine (25.4%). Isolate 
confirmations were conducted using conventional biochemical tests and confirmed by the 
API 20E system, and then the isolates were stored at –76°C in glycerol skim milk broth. 
Antimicrobial susceptibility tests were performed by using the disk-diffusion method 
according to Clinical and Laboratory Standards Institute (CLSI) guidelines
(12)
 for four 
aminoglycosides [amikacin (30 μg), gentamicin (10 μg), tobramycin (10 μg) and netilmicin 
(30 μg)]. All drugs were obtained from (Bioanalyse company-Turkey). E. coli ATCC 25922 
served as a control for the disk diffusion test. 
Polymerase chain reaction (PCR) was used to screen for the presence of the 
aminoglycosides modifying enzyme genes:aac(3)-I, aac(3)-II, aac(6')-I, aac(6')Ib, Aph(3')-
IV, Ant(4')-IIb and16rRNA methylase genes ( armA, rmtA, rmtD and npmA ). The total 
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template DNA for the PCR amplification was extracted from the supernatant of a mixture of 
P. aeruginosa cells produced by salting out method 
(13)
. PCR amplification was performed 
using 5 μl of the template DNA, 2 μl of each primer, 10 μl master mix, and 1 μl of Taq DNA 
polymerase in a total volume of 20 μl. A thermocycler (Mastercycler gradient; Eppendorf, 
Hamburg, Germany) was programmed with the appropriate conditions
(13)
. Then, 5μl of each 
PCR product was analyzed by electrophoresis on 1.5% (w/v) TAE agarose gel containing 
0.1 μl/mL ethidium bromide (14). The amplicon were then visualized on a UV 
transilluminator and photographed (BioDoc-Analyse; Biometra, Goettingen, Germany). 
STATISTICAL ANALYSIS: 
All statistical analyses were performed using Statistical Package for Social Sciences (SPSS) 
software. P-values of <0.05 were considered significant. L.S.D. values were compared with 
values of means difference. 
RESULTS: 
A total of 355 clinical samples have been collected, the distribution of clinical samples 
was explained in table 1. 160 (45.1%) were collected from ear while 105(29.6%) and 90 
(54.9) samples were collected from burn and urine respectively. According to the gender 
160 (45.1) samples were collected from female while 195 (54.9%) samples were collected 
from male. Outpatient constituted 260 (73.2%) and 95 (26.8%) samples from inpatient. 
Table 1: Distribution of 355 clinical samples according to the type, gender and 
hospitalization 
Type of sample Gender 
Male Female 
Total 
number 
Hospitalization 
Outpatient     Inpatient 
Total 
number 
Ear 
Burn 
Urine 
90              70 
55              50 
50              40 
160(45.1%) 
105(29.6%) 
90(25.4%) 
120                  40 
80       25 
60      30 
160(45.1%) 
105(29.6%) 
90(25.4%) 
Total 195(54.9%)160(45.1%) 355 260(73.2%)95(26.8%) 355 
Only 65 (18.3%) isolates were belonging to P. aeruginosa in which 25% of them were 
isolated from ear swab while 16.2% and 8.9% were isolated from burn and urine 
respectively. 
Table 2: Incidence of the isolated microorganisms in different clinical sample sites 
Source of samples No. of 
samples 
No.(%) of P. 
aeruginosa 
isolates 
No.(%) of  Gram 
positive and 
negative isolates 
No.(%) of no growth or 
contaminated cultures 
Ear 160 40 (25) 50 (31.3) 70 (43.7) 
Burn wound 105 17 (16.2) 38 (36.2) 50 (47.6) 
Urine 90 8  (8.9) 24 (26.7) 58 (64.4) 
Total 355 65 (18.3) 112 (31.6) 178 (50.1) 
A significant differences in number of isolates were found between male and female 
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Table 3: Distributions of 65 P. aeruginosa isolates based on age, gender and 
hospitalization 
Patients profile with positive P. 
aeruginosa 
Status No. (%) of P. aeruginosa isolates (n=65) 
 
 
Age group 
(years) 
(1-20) 
(21-40) 
(41-60) 
(over 61) 
11 (17.0) 
31 (47.7) 
13 (20) 
10 (15.3) 
 
Gender 
L.S.D. (0.05 )     (4.7) 
Male 
Female 
26(40) 
39(60)* 
Hospitalization Outpatient 
Inpatient 
40 (61.5)* 
25 (38.5) 
* T test is significant in P<0.05
 
The isolated bacteria showed variable results of resistance to aminoglycosides: 
gentamicin, amikacin, netilmicin and tobramycin. Based on the results from susceptibility 
testing, 29 (44.6%) of 65 P. aeruginosa isolates were found to be resistant to at least one of 
aminoglycosides, comprising 30 isolates (46.2%) susceptible and 6 (9.2%) with intermediate 
susceptibility. 
Table 4: Incidence of antibiotic resistance in P. aeruginosa isolates (n= 65) 
Antibiotic Sensitive % Intermediate % Resistant % 
Amikacin 52 80.0 1 1.5 12 18.5 
Gentamicin 30 46.2 6 9.2 29 44.6 
Netilmicin 45 69.2 7 10.8 13 20 
Tobramycin 39 60 5 7.7 21 32.3 
To investigate the mechanism of aminoglycosides resistance among P. aeruginosa. 
Table (5) showed the distribution of aminoglycosides resistance genes among 
aminoglycoside resistance P. aeruginosa isolates. The results showed the presence of aac(6')-
Ibin 21 (%) isolate of aminoglycoside resistance isolates. Figure (2 a and b). 
Table 5: Distribution of various aminoglycosides-resistance genes and their 
combinations and aminoglycosides resistant profiles in AACs carried P. aeruginosa 
isolates (n=21) 
Occurrence of gene No.(%) of isolates Isolate code 
No. 
Aminoglycosides resistant 
profile 
aac(6')-Ib 
 
 
 
 
10 (34.4) 
 
 
 
26, 28, 29, 63 CN 
38, 57 AK, CN, TOB 
42, 52 CN, TOB 
13 CN, NET, TOB 
64 AK, CN, NET, TOB 
aac(6')-Ib + aac(6')-I 5(17.2) 11, 24, 25 CN, NET, TOB 
21, 35 AK, CN, NET, TOB 
aac(6')-Ib + aac(3)-II 2 (6.9) 23 CN, NET, TOB 
46 CN 
aac(6')-Ib + aac(3)-I 1 (3.5 17 AK, CN, NET, TOB 
aac(3)-I 1 (3.5) 15 AK, CN, NET, TOB 
aac(6')-Ib+ aac(6')-I + 
aac(3)-II 
1 (3.5) 40 AK, CN, TOB 
aac(6')-Ib+ aac(6')-I + 
aac(3)-I 
1 (3.5) 19 CN, NET, TOB 
AME and 16rRNA 
methylase genes negative 
Isolates 
8 (27.6%) 1, 45 AK, CN, TOB 
7, 16, 58, 62 CN 
9, 12 AK, CN, NET, TOB 
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Figure (1): Ethidium bromide-stained agarose gel of PCR amplified products from 
extracted DNA of Pseudomonas aeruginosa amplified with aac(3)-I gene primers. The 
electrophoresis performed at 60 volt for 2hr. Lane (L), DNA molecular size marker 
(1500-bp ladder). Lanes (7, 9, 10) of isolates show positive results with aac(3)-I (117 
bp). 
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Figure (2 a and b): Ethidium bromide-stained agarose gel of PCR amplified products 
from extracted DNA of Pseudomonas aeruginosa amplified with aac(6')-Ib gene 
primers. The electrophoresis performed at 60 volt for 2 hr. Lane (L), DNA molecular 
size marker (1500-bp ladder). Lanes ( 4 , 6 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 
, 20 , 21 , 23 , 24 , 25 , 28 , 29 ) of isolates show positive results with aac(6')-Ib (524 bp). 
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Figure (3 a and b): Ethidium bromide-stained agarose gel of PCR amplified products 
from extracted DNA of Pseudomonas aeruginosa amplified with aac(6')-I gene 
primers. The electrophoresis performed at 60 volt for 2 hr. Lane (L), DNA molecular 
size marker (1500-bp ladder). Lanes ( 4 , 10 , 11 , 13 , 14 , 18 , 20 ) of isolates show 
positive results with aac(6')-I (400bp). 
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Figure (4 a and b): Ethidium bromide-stained agarose gel of PCR amplified products 
from extracted DNA of Pseudomonas aeruginosa amplified with aac(3)-II gene 
primers. The electrophoresis performed at 60 volt for 2 hr. Lane (L), DNA molecular 
size marker (1500-bp ladder). Lanes (12, 20, 23) of isolates show positive results with 
aac(3)-II (865 bp).  
DISCUSSION 
The incidence of P. aeruginosa among the examined samples was 65 positive isolates 
with a percentage of 18.3%. This incidence corresponds with many publications in Iraq
 (14, 15, 
16)
. The present investigation found that P. aeruginosa was most commonly isolated (25%) 
from the ear infection and this consistent with some previous surveillance studies 
(17, 9)
. 
Previous studies performed in burn hospitals in various cities of Iraq 
(15, 10)
, demonstrated 
high incidence of these isolates. The results of the present study showed that out of the entire 
burn culture positive, 16.2% exhibited P. aeruginosa isolates. Out of 90 patients with UTI, 
8.9% patients had an established P. aeruginosa etiology. This rate was comparable with 
study recorded 9.8% P. aeruginosa among urine infection in Najaf 
(11)
. 
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This study has focused on resistance to four types of aminoglycosides in clinically 
isolates of P. aeruginosa from hospitals, with emphasis on gentamicin, tobramycin, 
netilmicin and amikacin. In this study the percentage of resistance to gentamicin (44.6%) 
was low when evaluated with previous reports published from Iraqi provinces, 74.6-87% 
(18, 
10)
. Interestingly, percentage of resistance to tobramycin (32.3%) was less than previous 
reports (62.2-77.1%) published in other studies 
(10, 11, 19)
. There are no available national 
surveillance data regarding the occurrence of resistance to netilmicin in Iraq. Present study 
reveals low incidence of resistance to netilmicin among the clinical isolates of P. aeruginosa 
(20%). Amikacin demonstrated excellent activity against P. aeruginosa isolates (80.0% 
susceptibility), which is consistent with results from other studies in Iraq 
(18, 15)
. The high 
activity of amikacin may be attributed to the presence of the aminohydroxybutyryl group, 
which generally prevents the enzymatic modification of amikacin at multiple positions 
without interfering with binding to the A site of rRNA 
(20)
. 
In the present study the aminoglycoside resistance rate in 29 isolates of P. aeruginosa 
was high (72.4%). Most of resistant isolates harbored at least one of AACs gene. The 
aac(6')-Ib and aac(6')-I were the most common detected AAC (69% and 24.1%, 
respectively). These results are similar to that has been observed in different studies in other 
countries 
(21, 22)
. Though AAC(3)-II has been reported to be rare enzyme in P. aeruginosa
(23)
, 
this was present in 10.3% of the isolates in the present study. Interestingly, ten of 
aminoglycoside-resistant isolates had a combination of two to three different resistance 
genes, and five different combinations were encountered, which is in contrast to several 
studies conducted in the USA and Europe, which reported that the majority of isolates 
exhibit only a single aminoglycoside modifying gene 
(22)
. The difference in the distribution 
of modifying enzymes may derive from differences in aminoglycoside prescription patterns, 
the selection of bacterial population or geographical differences in the occurrence of 
aminoglycoside resistance genes. Results revealed that all of the isolates tested were found 
to be negative in the PCRs technique for the presence 16rRNA methylase genes, aph(3')-VI 
and ant(4')-IIb. The results support the hypothesis that AACs is representing the dominant 
aminoglycosides resistant type in P. aeruginosa isolates. 
The 21 of 29 aminoglycosides resistant isolates carrying plasmid-borne aac genes 
revealed unexpected resistance phenotypes. For example, when an isolate harbored only the 
aac (3)-I gene (isolate no. 15) which confer resistance to gentamicin, tobramycin and 
netilmicin but exhibited susceptibility to amikacin, resistance to amikacin, gentamicin, 
tobramycin and netilmicin was observed. We presume that the reason for this phenomenon 
might be the action of other resistance mechanisms, such as impermeability, efflux pumps, 
or other types of modifying enzymes.
(4)
Interestingly, the current investigation did not 
discover any of resistant genes to aminoglycosides in 8 isolates in spite of the presence of 
the aminoglycosides resistance phenotypes. The present study speculate that other resistance 
mechanisms including the reduction of antibiotic penetration on the outer membrane protein, 
and augmented excretion by an efflux pump system may exist
(8)
. However, compared with 
the aminoglycosides susceptibility results, there was no evident correlation between the 
presence of a particular AAC enzyme and the resistance pattern and this finding needs 
further investigation. 
CONCLUSIONS: 
The aminoglycosides resistance rates in P. aeruginosa were roughly high in Al-
Nasseryia, and most of the resistance isolates harbored aac (6')-Ib gene. 
KUFA JOURNAL FOR NURSING SCIENCES Vol.5 No. 1, January through April 2015 
 
 -10-  
 
RECOMMENDATIONS: 
In order to overcome the worrisome development of increased resistance to 
antibiotics in general and aminoglycoside in particular, continued national surveillance 
programs are crucial. 
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